{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:48:38Z","timestamp":1772311718413,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Patienten mit systemischen Autoimmun- und\/oder autoinflammatorischen Erkrankungen (AI\/AInf) bed\u00fcrfen in der Regel einer multidisziplin\u00e4ren Zusammenarbeit durch verschiedene Fachrichtungen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ziel der Arbeit (Fragestellung)<\/jats:title>\n                <jats:p>Wir evaluierten, ob die Etablierung eines multidisziplin\u00e4ren Boards (sog. Rheumaboard [RB]) zur Optimierung der Versorgung von Patienten mit Psoriasisarthritis (PsA) oder anderen AI\/AInf f\u00fchrt.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material und Methoden<\/jats:title>\n                <jats:p>Es wurden <jats:italic>n<\/jats:italic>\u202f=\u2009272\u00a0Patienten mit AI\/AInf eingeschlossen, die in 3\u00a0Gruppen eingeteilt wurden; Gruppe\u00a01: 41\u00a0Patienten mit oder mit Verdacht auf (V.\u202fa.) PsA, von der Dermatologie in der Rheumatologie konsiliarisch avisiert; Gruppe\u00a02: 166\u00a0Patienten mit oder mit V.\u202fa. PsA, vorstellig in der Dermatologie und im RB; Gruppe\u00a03: 65\u00a0Patienten mit anderen AI\/AInf, vorstellig in der Dermatologie und im RB. Evaluiert wurde die durchschnittliche Zeit von der initialen Vorstellung bis zur Therapieeinleitung nach erfolgter Beurteilung und Diagnostik durch beide Fachrichtungen. Dar\u00fcber hinaus wurden die Diagnosesicherung\/-best\u00e4tigung und die Therapieweiterf\u00fchrung\/-optimierung bei allen 3\u00a0Gruppen analysiert.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Die durchschnittliche Zeitspanne von der initialen Vorstellung bis zur Therapieeinleitung betrug in Gruppe\u00a01 85\u202f\u00b1\u200942,24 (5 bis 173) Tage, in Gruppe\u00a02 15\u202f\u00b1\u200913,09 (0 bis 78) Tage und in Gruppe\u00a03 20\u202f\u00b1\u200916,71 (1 bis 75) Tage. In Gruppe\u00a02 und\u00a03 konnte die Diagnose schneller gesichert oder best\u00e4tigt sowie die Wartezeit auf Diagnostik und Therapie deutlich reduziert werden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Diskussion<\/jats:title>\n                <jats:p>Durch die Etablierung eines RB zeigt sich eine signifikante Verk\u00fcrzung der Zeitspanne zwischen Erstvorstellung und Therapieeinleitung und damit eine deutliche Verbesserung des Versorgungsmanagements bei Patienten mit AI\/AInf inklusive Diagnosesicherung und Therapieoptimierung.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphic abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00105-022-05051-z","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T10:06:09Z","timestamp":1662545169000},"page":"866-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multidisziplinarit\u00e4t als Schl\u00fcssel zum Erfolg","Multidisciplinarity as the key to success"],"prefix":"10.1007","volume":"73","author":[{"given":"Petra","family":"Staubach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Veelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berenice M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriane","family":"Peveling-Oberhag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Grabbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Kaluza-Schilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schwarting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"5051_CR1","first-page":"20","volume":"9","author":"GO Abdulrahman Jr.","year":"2011","unstructured":"Abdulrahman\u00a0GO Jr. (2011) The effect of multidisciplinary team care on cancer management. Pan Afr Med\u00a0J 9:20","journal-title":"Pan Afr Med J"},{"issue":"1","key":"5051_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","volume":"80","author":"F Alinaghi","year":"2019","unstructured":"Alinaghi\u00a0F et al (2019) Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J\u00a0Am Acad Dermatol 80(1):251\u2013265.e19","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"5051_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/ced.14390","volume":"46","author":"Y Argobi","year":"2021","unstructured":"Argobi\u00a0Y, Smith\u00a0GP (2021) Analysis of the first 5\u00a0years of an interdisciplinary Rheumatology-Dermatology clinic. Clin Exp Dermatol 46(2):270\u2013275","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"5051_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1586\/14737167.2014.914437","volume":"14","author":"M Augustin","year":"2014","unstructured":"Augustin\u00a0M, Radtke\u00a0MA (2014) Quality of life in psoriasis patients. Expert Rev Pharmacoecon Outcomes Res 14(4):559\u2013568","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"5","key":"5051_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/jamaophthalmol.2017.0569","volume":"135","author":"CC Chi","year":"2017","unstructured":"Chi\u00a0CC et\u00a0al (2017) Risk of uveitis among people with psoriasis: A nationwide cohort study. JAMA Ophthalmol 135(5):415\u2013422","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"5051_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","volume":"2","author":"GS Cooper","year":"2003","unstructured":"Cooper\u00a0GS, Stroehla\u00a0BC (2003) The epidemiology of autoimmune diseases. Autoimmun Rev 2(3):119\u2013125","journal-title":"Autoimmun Rev"},{"issue":"9","key":"5051_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.bjc.6602825","volume":"93","author":"LM Forrest","year":"2005","unstructured":"Forrest\u00a0LM et al (2005) An evaluation of the impact of a\u00a0multidisciplinary team, in a\u00a0single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 93(9):977\u2013978","journal-title":"Br J Cancer"},{"issue":"14","key":"5051_CR8","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand\u00a0JM et\u00a0al (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296(14):1735\u20131741","journal-title":"JAMA"},{"issue":"12","key":"5051_CR9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","volume":"143","author":"JM Gelfand","year":"2007","unstructured":"Gelfand\u00a0JM et al (2007) The risk of mortality in patients with psoriasis: results from a\u00a0population-based study. Arch Dermatol 143(12):1493\u20131499","journal-title":"Arch Dermatol"},{"issue":"8","key":"5051_CR10","first-page":"891","volume":"146","author":"SK Kurd","year":"2010","unstructured":"Kurd\u00a0SK et al (2010) The risk of depression, anxiety, and suicidality in patients with psoriasis: A\u00a0population-based cohort study. Arch Dermatol 146(8):891\u2013895","journal-title":"Arch Dermatol"},{"issue":"2","key":"5051_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","volume":"156","author":"RJ Ludwig","year":"2007","unstructured":"Ludwig\u00a0RJ et\u00a0al (2007) Psoriasis: a\u00a0possible risk factor for development of coronary artery calcification. Br J Dermatol 156(2):271\u2013276","journal-title":"Br J Dermatol"},{"issue":"3","key":"5051_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jaad.2009.02.015","volume":"61","author":"M Makredes","year":"2009","unstructured":"Makredes\u00a0M et\u00a0al (2009) The burden of autoimmune disease: a\u00a0comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J\u00a0Am Acad Dermatol 61(3):405\u2013410","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"5051_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","volume":"31","author":"NN Mehta","year":"2010","unstructured":"Mehta\u00a0NN et\u00a0al (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart\u00a0J 31(8):1000\u20131006","journal-title":"Eur Heart J"},{"issue":"4","key":"5051_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","volume":"41","author":"A Ogdie","year":"2015","unstructured":"Ogdie\u00a0A, Weiss\u00a0P (2015) The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am 41(4):545\u2013568","journal-title":"Rheum Dis Clin North Am"},{"issue":"7","key":"5051_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2478\/v10035-012-0063-7","volume":"84","author":"R Sitarz","year":"2012","unstructured":"Sitarz\u00a0R et\u00a0al (2012) Effective cancer treatment by multidisciplinary teams. Pol Przegl Chir 84(7):371\u2013376","journal-title":"Pol Przegl Chir"},{"issue":"7","key":"5051_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","volume":"298","author":"DM Sommer","year":"2006","unstructured":"Sommer\u00a0DM et\u00a0al (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298(7):321\u2013328","journal-title":"Arch Dermatol Res"},{"issue":"Suppl 2","key":"5051_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2133.2008.08780.x","volume":"159","author":"F Sp\u00e4h","year":"2008","unstructured":"Sp\u00e4h\u00a0F (2008) Inflammation in atherosclerosis and psoriasis: Common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 159(Suppl 2):10\u201317","journal-title":"Br J Dermatol"},{"issue":"1","key":"5051_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00403-011-1172-6","volume":"304","author":"NF Velez","year":"2012","unstructured":"Velez\u00a0NF et\u00a0al (2012) Management of psoriasis and psoriatic arthritis in a\u00a0combined dermatology and rheumatology clinic. Arch Dermatol Res 304(1):7\u201313","journal-title":"Arch Dermatol Res"},{"issue":"9","key":"5051_CR19","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2105\/AJPH.90.9.1463","volume":"90","author":"SJ Walsh","year":"2000","unstructured":"Walsh\u00a0SJ, Rau\u00a0LM (2000) Autoimmune diseases: a\u00a0leading cause of death among young and middle-aged women in the United States. Am J Public Health 90(9):1463\u20131466","journal-title":"Am J Public Health"},{"key":"5051_CR20","unstructured":"World Health Organization (2016) Global report on psoriasis. https:\/\/apps.who.int\/iris\/handle\/10665\/204417. Zugegriffen: 25. Sept. 2021"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-022-05051-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-022-05051-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-022-05051-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T08:04:42Z","timestamp":1666598682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-022-05051-z"}},"subtitle":["Zusammenarbeit zwischen Dermatologie und Rheumatologie zur Optimierung der Patientenversorgung","Cooperation between dermatology and rheumatology to optimize patient care"],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["5051"],"URL":"https:\/\/doi.org\/10.1007\/s00105-022-05051-z","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"27 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Staubach, K.\u00a0Veelen, S.\u00a0Zimmer, A.\u00a0Sohn, B.M.\u00a0Lang, A.\u00a0Peveling-Oberhag, S.\u00a0Grabbe, W.\u00a0Kaluza-Schilling, A.\u00a0Schwarting und J.\u00a0Wegner geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}